Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

about

Response to Comment on: Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Item

http://www.wikidata.org/entity/Q36289343

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Response to Comment on: Treatm ...... nal vein occlusion in the USA.

@ast

Response to Comment on: Treatm ...... nal vein occlusion in the USA.

@en

type

Item

label

Response to Comment on: Treatm ...... nal vein occlusion in the USA.

@ast

Response to Comment on: Treatm ...... nal vein occlusion in the USA.

@en

prefLabel

Response to Comment on: Treatm ...... nal vein occlusion in the USA.

@ast

Response to Comment on: Treatm ...... nal vein occlusion in the USA.

@en

P1476

Response to Comment on: Treatm ...... nal vein occlusion in the USA.

@en

P2093

A Skelly

http://www.w3.org/2001/XMLSchema#string

A Sodi

http://www.w3.org/2001/XMLSchema#string

N Yu

http://www.w3.org/2001/XMLSchema#string

S Baillif

http://www.w3.org/2001/XMLSchema#string

S Nghiem-Buffet

http://www.w3.org/2001/XMLSchema#string

S Regnier

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the U.S.A.

Response to 'Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the U.S.A.'.

A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

P2888

eye.2017.15

P304

1113-1114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2017.15

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28234353

http://www.w3.org/2001/XMLSchema#string

P921

dexamethasone

P932

5519263

http://www.w3.org/2001/XMLSchema#string